[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.13.1″]
In recent years, important advances have already been made in the study of the human genome that can help in the progress of personalized medicine.
This area is aimed at a more preventive medicine based on continuous care, improve diagnosis and offer optimal treatment options and consequently lower health costs.
The use of genomic biomarkers nowadays is normal for the classification of common and uncommon disease and for the prognosis of response to treatments. The diagnosis of the genetic disease is a healthcare reality, although there are different schemes and inequalities according to the territorial scope.
These and other innovations are now possible in Pharmamedic.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
